UPDATE: Arena Pharmaceuticals (ARNA) Narrows Q4 GAAP Loss to 10c/Share
Tweet Send to a Friend
(Updated - March 4, 2013 7:04 AM EST)
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q4 GAAP loss of $0.10 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q4 GAAP loss of $0.10 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
